Connect with us

Health

Novel candidate malaria vaccine confers high levels of durable protection – News-Medical.Net

Two U.S. Phase 1 clinical trials of a novel candidate malaria vaccine have found that the regimen conferred unprecedentedly high…

Published

on

Article feature image

Two U.S. Phase 1 clinical trials of a novel candidate malaria vaccine have found that the regimen conferred unprecedentedly high levels of durable protection when volunteers were later exposed to disease-causing malaria parasites. The vaccine combines live…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending